State Street’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-7,817
| Closed | -$27K | – | 4299 |
|
|
2024
Q3 | $27K | Hold |
7,817
| – | – | ﹤0.01% | 4190 |
|
|
2024
Q2 | $39.7K | Buy |
7,817
+1,413
| +22% | +$7.18K | ﹤0.01% | 4187 |
|
|
2024
Q1 | $54.2K | Hold |
6,404
| – | – | ﹤0.01% | 4144 |
|
|
2023
Q4 | $26.2K | Hold |
6,404
| – | – | ﹤0.01% | 4312 |
|
|
2023
Q3 | $19.2K | Hold |
6,404
| – | – | ﹤0.01% | 4447 |
|
|
2023
Q2 | $198K | Hold |
6,404
| – | – | ﹤0.01% | 4016 |
|
|
2023
Q1 | $317K | Hold |
6,404
| – | – | ﹤0.01% | 3905 |
|
|
2022
Q4 | $158K | Hold |
6,404
| – | – | ﹤0.01% | 4202 |
|
|
2022
Q3 | $425K | Hold |
6,404
| – | – | ﹤0.01% | 3839 |
|
|
2022
Q2 | $265K | Hold |
6,404
| – | – | ﹤0.01% | 4087 |
|
|
2022
Q1 | $323K | Buy |
6,404
+624
| +11% | +$31.5K | ﹤0.01% | 4211 |
|
|
2021
Q4 | $347K | Hold |
5,780
| – | – | ﹤0.01% | 4139 |
|
|
2021
Q3 | $286K | Hold |
5,780
| – | – | ﹤0.01% | 4222 |
|
|
2021
Q2 | $329K | Sell |
5,780
-28,711
| -83% | -$1.63M | ﹤0.01% | 4018 |
|
|
2021
Q1 | $1.98M | Buy |
34,491
+2,845
| +9% | +$163K | ﹤0.01% | 3442 |
|
|
2020
Q4 | $2.15M | Buy |
31,646
+613
| +2% | +$41.6K | ﹤0.01% | 3342 |
|
|
2020
Q3 | $7.88M | Buy |
31,033
+2,854
| +10% | +$724K | ﹤0.01% | 2564 |
|
|
2020
Q2 | $4.74M | Buy |
+28,179
| New | +$4.74M | ﹤0.01% | 2782 |
|